CMS advised Bruker on the acquisition of an additional 60% ownership stake in Tofwerk, a Switzerland-based company, specialised in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets. Pursuant to the deal, Bruker